---
$id: https://graph.org.ai/products/commodity/51432809
$type: Product
source: UNSPSC
code: "51432809"
title: "Lisinopril anhydrous"
class: "51432800"
classTitle: "Antihypertensive oligopeptides"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lisinopril anhydrous

**UNSPSC Code**: 51432809
**Class**: [Antihypertensive oligopeptides](Antihypertensive oligopeptides.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor with the molecular formula C21H31N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Q3P4BS2FD, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, but more generally known as lisinopril anhydrous, which bears US NIH Compound Identifier 5362119. European Medicines Agency schedules lisinopril anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08533MIG. Most nations, for tariff purposes, schedule lisinopril anhydrous under HS 29339990. Lisinopril anhydrous bears US NLM identifiers UMLS ID C2827257 and NCI Concept Code C83924. SMILES: C1CCC(CC1)CC[C@@H](C(=O)O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)O.

